US Patent Issued to INTRA-CELLULAR THERAPIES on June 10 for "Organic compounds" (New York, New Jersey, California Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,726, issued on June 10, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.).

"Organic compounds" was invented by Kimberly Vanover (New York), Peng Li (New Milford, N.J.), Robert Davis (San Diego) and Yupu Qiao (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to particular prodrugs and analogs of (3Alpha,5Alpha)-3-hydroxy-21-(1H-imidazol-1-yl)-3-methoxymethyl)-pregnan-20-one, in free or pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use as sedatives, hypnotics, anxiolytics, and/or anesthetics, and methods for treatment ...